glp-1 receptor agonist examples Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Description
These drugs aid in harmony since they control the eating centers of the brain and the craving ones as well
Jaensch, N., Corra, I

Methods Data sources We used data from the UK Clinical Practice Research Datalink (CPRD) GOLD and Aurum, which was linked to the Hospital Episode Statistics Admitted Patient Care (HES APC) and Office for National Statistics (ONS) Death Registration databases

Prather, a subtype of osteoarthritismetabolic osteoarthritisprogresses in relationship to metabolic conditions including type 2 diabetes, obesity, hypertension, hyperlipidemia and cardiovascular disease

However, due to its indicated short half-live, GLP-1 peptide is an unattractive therapeutic agent on itself, which stimulated the quest for GLP-1 based compounds with better bioavailability

[2] Regular monitoring is essential, including blood tests to assess disease activity (CRP, ESR), drug safety (liver and kidney function, blood counts), and periodic imaging to detect joint damage
